Guangzhou Women And Children's Medical Center

This is a very early, small study to test the safety of a single dose of an experimental gene therapy called YOLT-204. It will enroll up to 18 children and teenagers with severe, transfusion-dependent forms of sickle cell disease or beta-thalassemia. The main goals are to see if …